Pharmacy Consulting

Pharmacy Healthcare Solutions Inc. (PHSI) consults with pharmaceutical manufacturers, PBMs, retail pharmacy chains, and software companies on strategic business and marketing issues. Consulting projects across these market segments provide PHSI with the latest information on emerging trends as well as new products and services. Our consultants have extensive retail, mail service and managed care experience to create actionable recommendations for our clients’ challenging business issues.

News & Events

Dave Schuetz and Fred Hamlin Attending NCPDP’s August Work Group Meetings

PHSI Director of Business Development Fred Hamlin and PHSI Consultant Dave Schuetz will be attending the NCPDP Joint Technical Work Group Meetings from August 12, 2015 through August 14, 2015 at the Hyatt Regency in Minneapolis, MN. The Work Group Meetings provide a venue for NCPDP members and industry stakeholders to come together to address Read More →

ComputerTalk for the Pharmacist May/June 2015

PHSI Consultants Alan Sekula and Ann Johnson contributed to the May/June 2015 edition of ComputerTalk for the Pharmacist. In their Viewpoints article, Alan and Ann review the impact that biosimiliars will have on various stakeholders: drug compendia, payers, wholesalers, pharmacies, and manufacturers.

PHSI to Attend NACDS Total Store Expo

PHSI President Tim Kosty, Vice President Don Dietz, and many of PHSI’s consultants will be attending the 2015 NACDS Total Store Expo in Denver, Colorado on August 22-25. PHSI will have an exhibit set up at booth number 2016. If you would like to schedule a meeting with a PHSI team member, please click here to send us Read More →

Latest from the Blog

Biosimilars & Originators – What’s the Link?

CMS issued a new guidance on biosimilar reimbursement. It sounds simple but now the drug compendia must link the biosimilar with the originator or someone else will meet this marketplace need.

Price Changes of Hydrocodone Combination Products

Following a scientific review of hydrocodone combination products that began in 2009, the FDA recommended in December 2013 that the DEA reclassify these as Schedule II Controlled Substances. The DEA ruling was published August 22, 2014 and rescheduling of hydrocodone combination products took effect on October 6, 2014. For retail pharmacists, this is old news. Read More →

Retail Pharmacy Clinical Services – Decision Criteria

Retail pharmacy is innovating by expanding clinical services. To obtain the best results, the clinical service implementation should be thoroughly evaluated. Listed below are suggested questions to use when evaluating the introduction of new retail pharmacy clinical services.   Questions   Is there evidence based studies that estimate the ROI for the provision of the Read More →